Methods to reimburse living organ donors for the nonmedical expenses they incur have been implemented in some jurisdictions and are being considered in others. A global understanding of existing legislation and programs would help decision makers implement and optimize policies and programs.
Introduction

About 27 000 living kidney transplants occur around the world each year, and the number is increasing (1). In addition, about 2000 living donor liver transplants are performed annually (2) and 250 living donor lung transplants have been performed worldwide (3). Living donor kidney transplantation is preferred to deceased donor transplantation or dialysis, as it improves recipient outcomes at a reduced cost to the healthcare system (4). It is estimated that one living kidney donation results in a net increase of 2 to 3.5 quality-adjusted life-years, and a net health care savings of $100 000 Canadian (5).
Non-medical expenses are frequently incurred by the living organ donor as part of the transplant process (6). These expenses include travel, parking, accommodation, meal and dependent care costs, as well as lost income.
One Canadian study estimated that 53% of organ donors incur transportation and parking costs (7) . In another American multi-center study, transportation and accommodation costs were reported by 99% and 88% of donors, respectively (8) . Lost income has been reported in 14-30% of organ donors, averaging as much as $4410 Canadian in 2004 (7, 9, 10) . In a single center study involving 133 potential donors to a family member, 24% chose not to donate because of anticipated financial hardship (11) . (12) (13) (14) (15) (16) (17) (18) (12, 13, 16 
Sickand et al.
To ease the financial burden of organ donation, experts advocate reimbursement of legitimate expenses, stating that it is just and ethically responsible, and should be considered a cost associated with treating living organ recipients
Materials and Methods
Data of interest
We considered countries where 10 (12, 16, 19, 20) .
or more living donations are performed each year, based on an average between 2004 and 2007 as described in the Global Observatory on Organ Transplantation and Horvat et al. (1,2). While reimbursement is implicit in payment programs, we excluded programs where payment is intended for financial gain, as this practice contravenes international recommendations and standards
The data collection plan is presented in Figure 1 (Table 3 ). Continued. Sickand et al. Continued. Sickand et al. 
Programs and policies in specific jurisdictions
Donor Reimbursement Programs
